Bristol-Myers Squibb - Corporate Responsibility


	Patient Assistance Programs
	Fighting AIDS in Africa
	Bristol-Myers Squibb Foundation & Corporate Philanthropy
	Product Integrity
	Sustainability: Our Plan for Responsible Growth
	Environment, Health & Safety Policy
	Medical Education Grants And Charitable Contributions
	Clinical Outcomes And Research Grants
	Position On Key Issues

» BMS.com Home » Corporate Responsibility » Position on Key Issues

Position on Key Issues

Bristol-Myers Squibb is a member of the Pharmaceutical Research and Manufacturers of America (PhRMA), an advocacy organization based in Washington, D.C., that represents the leading research-based pharmaceutical and biotechnology companies in the United States. On this page, you will find links to information on PhRMA and on key issues supported by Bristol-Myers Squibb and PhRMA.

Clinical Trial Communication Commitment

Commitment to Medicare Beneficiaries

Endorsement of PhRMA's Code on Interactions with Health Care Professionals

Endorsement of PhRMA's Guiding Principles on Direct-to-Consumer Advertisements

PhRMA Annual Report

Policy on Stockholder Rights Plan

Political Contributions

Sustaining Our Intellectual Property

U.S. Health Care Reform

[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.